http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103937744-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-09 |
| filingDate | 2014-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103937744-B |
| titleOfInvention | A kind of human bile duct cancer drug-resistant cell strain and application thereof |
| abstract | The present invention relates to a kind of human bile duct cancer drug-resistant cell strain, deposit number is CCTCC No:C201441.The present invention selects human bile duct cancer RBE cell strain as parental cell, adds 5 FU and cultivates, and is stepped up its activity according to the concentration order of 25,50,75,100 g/ml, sets up human bile duct cancer drug-resistant cell strain.The human bile duct cancer drug-resistant cell strain RBE/5 FU of the present invention can be research tumor drug resistance mechanism, analyzes chemotherapy drug susceptibility and screening and assessment chemotherapeutics, develops tumor drug resistance reversal medicine, study the offer cells of resistant tumors models such as more effective tumor therapeuticing method. |
| priorityDate | 2014-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 33.